Results 131 to 140 of about 4,295 (215)

Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancer. [PDF]

J Manag Care Spec Pharm
Kamat S, Brown BR, Cohen SA, Vyas A.
europepmc   +1 more source

A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy. [PDF]

Support Care Cancer
Harikul W, Nimmannit A, Laocharoenkeat A, Phisalprapa P, Kositamongkol C, Thongkijpreecha P, Ithimakin S.   +6 more
europepmc   +1 more source

Palonosetron Hydrochloride [PDF]

, 2020
openaire   +1 more source

Palonosetron versus tropisetron with dexamethasone for prevention of postoperative nausea and vomiting in pediatric adenotonsillectomy: a single center, randomized controlled trial. [PDF]

Front Med (Lausanne)
Chen H, Sun L, Zheng J, Gu H.
europepmc   +1 more source

5-HT regulates resistance to aumolertinib by attenuating ferroptosis in lung adenocarcinoma. [PDF]

EMBO Mol Med
Feng Y, He Y, Zuo R, Gong W, Gao Y, Wang Y, Wang Y, Chen W, Chen L, Luo Y, Yuan D, Chen P, Guo H.   +12 more
europepmc   +1 more source

STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]

Cureus
Shukla P, Valame S, Nanda S, Shakya NK, Verma AK, Hanji A, Pednekar A, Bhagat S, Patil S, Petare AU, Bhushan S, Barkate H.   +11 more
europepmc   +1 more source

Netupitant/Palonosetron Hydrochloride [PDF]

, 2020
openaire   +1 more source

Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates [PDF]

, 2015

core   +1 more source

Validation of Steroid-Sparing Therapy in Patients Receiving Oxaliplatin-based Chemotherapy: A before-and-after Prospective Observational Study. [PDF]

Asian Pac J Cancer Prev
Yamamoto Y, Watanabe N, Goshima A, Hayashi H, Fukuoka T, Ando M, Kawahara M.   +6 more
europepmc   +1 more source

Fosnetupitant/Palonosetron Hydrochloride [PDF]

, 2020
openaire   +1 more source